Die neuesten TTNP Reports werden am 2024-05-15 aktualisiert: 2024-Q12023-Q42023-Q1
Titan Pharmaceuticals logo
Titan Pharmaceuticals TTNP
€ 6.33 0.0%

Titan Pharmaceuticals Kennzahlen 2011-2024 | TTNP

Kennzahlen Jährlich Titan Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.9 -0.1 -1.2 - -0.4 -1.6 -2.0 16.4 -6.3 -18.8 6.1 -8.1 -4.7

P/S

28.4 0.9 6.6 2.1 1.7 2.4 133.1 5.6 42.4 12.4 5.7 17.3 17.4

EPS

-7.4 -15.2 - -2.0 -0.7 -1.6 -0.7 0.2 -0.6 -0.0 0.1 -0.2 -0.3

EV (Enterprise Value)

-82.1 K 275 K 6.93 M 9.45 M 9.06 M 12.3 M 29.1 M 75.5 M 69.2 M 42 M 60.2 M 153 M 95.8 M

EBITDA per Share

-9.53 -14.9 -0.92 -2.16 -21.7 -19.8 -120 41 -57.5 -32.9 -9.45 -124 -175

EV/EBITDA

-0.7 -0.8 -0.3 -1.2 -2.0 14.8 -9.8 -9.5 -60.7 -14.0 -7.4

PEG

-0.0 -0.0 0.01 - -0.05 -0.02 0.01 0.11 0.03 0.15 0.04 -0.7 0.02

P/B

0.8 0.4 2.0 2.9 4.3 2.1 33.4 6.4 10.1 5.3 10.3 -5.3 -3.5

P/CF

-0.7 -0.1 -1.3 -0.6 -0.4 -1.6 -2.2 13.7 -9.3 -7.7 -5.9 181.8 -4.8

ROE %

-83.85 -748.79 -170.81 - -1148.50 -132.09 -1669.43 38.93 -161.36 -27.91 168.59 65.63 75.72

ROA %

-68.87 -251.50 -109.78 - -172.84 -64.02 -160.66 27.51 -84.89 -11.52 52.71 -61.14 -148.80

ROCE %

-109.56 -750.92 -182.06 -190.24 -284.43 -77.65 -326.55 31.45 -80.14 -24.49 -11.76 -243.74 -206.24

Current Ratio

5.6 1.5 2.8 1.7 2.3 3.9 1.9 3.7 2.5 2.9 1.6 1.1 1.9

DSO

81.3 48.5 119.1 - 100.4 113.4 110.3 86.9 920.3 397.2 167.8 238.3 333.8

DIO

- - 569.5 253.6 282.8 856.2 - - - - - - -

DPO

- - 1878.2 969.0 397.0 1035.3 - - - - - - -

Betriebszyklus

81.3 48.5 688.6 253.6 383.2 969.6 - - - - - - -

Finanzkreislauf

81.3 48.5 -1189.6 -715.3 -13.8 -65.7 - - - - - - -

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Titan Pharmaceuticals

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-1.24 - -0.02 -0.11 -2.23 - -0.18 -0.18 -0.24 - - -0.17 -0.28 - -0.05 -0.05 -0.07 -0.08 -0.18 -0.38 -0.34 -0.29 -0.64 -0.25 -0.74 -1.04 -0.2 -0.16 -0.14 -0.11 -0.12 0.58 -0.09 -0.11 -0.09 -0.11 -0.24 -0.02 0.04 -0.01 -0.02 - -0.01 0.06 0.08 - -0.12 -0.03 -0.09 -0.05 -0.01 -0.12 -0.08

EBITDA per Share

-1.24 - - - -2.2 - -0.17 -0.17 -0.23 - -0.18 -0.22 -0.28 - -0.3 -0.47 -0.69 - -238 -0.35 -0.32 - -442 -0.02 -0.11 - -0.18 -0.16 -0.16 - -0.11 0.6 -0.09 - -0.08 -0.05 -0.08 - -0.03 - -0.01 - - - - - -0.04 -0.03 -0.06 - - - -

ROE %

127.66 686.09 611.78 541.62 344.79 -149.98 -175.53 -126.76 -102.53 -71.22 -210.85 -324.94 -437.14 -429.13 -704.15 -760.12 -991.38 -1148.50 -924.78 -759.11 -409.17 -132.09 -507.86 -966.96 -1356.92 -1669.43 -1260.00 -790.83 -297.72 38.93 23.75 17.76 -105.30 -161.36 -134.03 -99.87 -77.01 -27.91 -26.04 -54.24 43.46 168.59 173.43 227.96 147.50 65.63 78.86 48.21 75.57 75.72 4.00 34.81 22.47

ROA %

-218.03 -275.96 -317.99 -356.65 -190.92 -96.25 -116.12 -93.95 -78.96 -53.58 -114.56 -155.68 -198.47 -187.42 -228.81 -197.26 -194.45 -172.84 -156.31 -141.38 -92.97 -64.02 -80.26 -112.81 -145.40 -160.66 -132.03 -99.00 3.65 27.51 22.71 23.14 -57.92 -84.89 -69.89 -52.86 -39.73 -11.52 -10.39 -20.04 11.49 52.71 52.72 26.66 -7.77 -61.14 -88.38 -63.97 -125.44 -148.80 -7.87 -68.41 -44.16

ROCE %

85.43 672.15 597.70 548.59 351.92 -149.75 -175.21 -126.21 -109.70 -78.41 -112.27 -120.68 -139.91 -135.59 -406.56 -643.67 -938.54 -910.68 -939.25 -696.86 -365.53 -73.17 -548.08 -994.42 -1407.58 -1298.48 -1318.31 -863.23 -349.41 57.59 31.81 25.86 -81.06 -64.51 -73.08 -55.87 -46.63 -25.80 -28.03 -21.68 -20.36 -4.32 7.17 20.88 33.46 34.28 44.03 42.28 55.68 48.51 9.75 20.92 17.84

Current Ratio

11.9 5.6 5.4 0.4 0.9 1.5 2.3 3.1 4.2 2.8 4.5 4.2 3.6 1.8 1.8 1.8 1.8 1.2 1.2 1.2 1.2 1.9 1.9 1.9 1.9 1.1 1.1 1.1 1.1 3.4 3.4 3.4 3.4 2.1 2.1 2.1 2.1 1.7 1.7 1.7 1.7 1.4 1.4 1.4 1.4 0.5 0.5 0.5 0.5 0.3 0.3 0.3 0.3

DSO

- - 399.2 9.3 20.5 - 72.0 97.0 78.4 - 63.6 51.4 85.8 - 79.2 64.6 53.6 53.6 95.7 180.5 131.8 128.2 96.1 59.4 77.3 102.3 148.3 77.0 4165.6 9351.8 12589.0 21.8 - - - 505.8 409.7 397.0 397.4 397.4 440.0 482.6 200.0 200.0 83.5 130.1 345.2 311.7 300.6 240.2 335.4 488.4 -

DIO

- - - - - - - - - - 59.1 177.9 226.5 - - - - - 484.4 370.2 339.2 - 647.0 1645.1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - 189.2 618.8 838.3 - - - - - 680.0 519.7 439.3 - 782.3 1989.2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

- - 399.2 9.3 20.5 - 72.0 97.0 78.4 - 122.8 229.3 312.2 - 79.2 64.6 53.6 53.6 580.1 550.7 471.0 128.2 743.0 1704.5 77.3 102.3 148.3 77.0 4165.6 9351.8 12589.0 21.8 - - - 505.8 409.7 397.0 397.4 397.4 440.0 482.6 200.0 200.0 83.5 130.1 345.2 311.7 300.6 240.2 335.4 488.4 -

Finanzkreislauf

- - 399.2 9.3 20.5 - 72.0 97.0 78.4 - -66.4 -389.5 -526.0 - 79.2 64.6 53.6 53.6 -99.9 31.0 31.7 128.2 -39.3 -284.7 77.3 102.3 148.3 77.0 4165.6 9351.8 12589.0 21.8 - - - 505.8 409.7 397.0 397.4 397.4 440.0 482.6 200.0 200.0 83.5 130.1 345.2 311.7 300.6 240.2 335.4 488.4 -

Alle Zahlen in USD-Währung